Related Experiment Video
Updated: Jul 23, 2025

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Published on: April 1, 2015
Bachmann-Bupp syndrome and treatment
André S Bachmann1,2, Elizabeth A VanSickle2,3, Julianne Michael2,3
1Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
Bachmann-Bupp syndrome (BABS) is a rare neurodevelopmental disorder caused by ODC1 gene mutations. Treatment with the ODC inhibitor DFMO shows promise for improving symptoms like hair loss and developmental delay.
Area of Science:
- Genetics
- Biochemistry
- Neurodevelopmental Disorders
Background:
- Bachmann-Bupp syndrome (BABS) is a rare neurodevelopmental disorder.
- It is characterized by developmental delay, hypotonia, and alopecia.
- BABS results from 3'-end mutations in the ornithine decarboxylase 1 (ODC1) gene.
Purpose of the Study:
- To investigate the molecular mechanisms underlying BABS.
- To explore the therapeutic potential of drug repurposing for BABS.
- To evaluate the efficacy of DFMO in treating BABS.
Main Methods:
- Analysis of ODC1 gene mutations.
- Studying the impact of C-terminal ODC truncation on enzyme degradation and activity.
- Clinical observation of BABS patients treated with DFMO.
Main Results:
- ODC1 mutations lead to C-terminally truncated ODC variants.
- Truncated ODC accumulates due to impaired proteasomal degradation, increasing ODC activity.
- DFMO treatment in BABS patients resulted in improvements in hair growth, muscle tone, and development.
Conclusions:
- ODC1 gene mutations and subsequent ODC accumulation are central to BABS pathogenesis.
- DFMO, an ODC inhibitor, is a viable therapeutic strategy for BABS.
- Drug repurposing with DFMO offers a promising treatment avenue for this ultra-rare condition.
Related Concept Videos
Bulimia Nervosa
Bipolar Disorder
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Psychosis: Goals of Pharmacotherapy
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

